View in EDS

High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidine.

Saved in:
Bibliographic Details
Title: High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidine.
Authors: Tiso F; Department of Laboratory Medicine, Laboratory of Hematology Radboud University Medical Center and Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands., In 't Hout FEM; Department of Laboratory Medicine, Laboratory of Hematology Radboud University Medical Center and Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands.; Department of Hematology Radboud University Medical Center Nijmegen The Netherlands., Knops R; Department of Laboratory Medicine, Laboratory of Hematology Radboud University Medical Center and Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands., Kroeze LI; Department of Pathology Radboud University Medical Center Nijmegen The Netherlands., van Rooij A; Department of Laboratory Medicine, Laboratory for Genetic, Endocrine, and Metabolic Diseases Radboud University Medical Center Nijmegen The Netherlands., van de Loosdrecht AA; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC Vrije Universiteit Amsterdam Amsterdam The Netherlands., Westers TM; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC Vrije Universiteit Amsterdam Amsterdam The Netherlands., Langemeijer SMC; Department of Hematology Radboud University Medical Center Nijmegen The Netherlands., Preudhomme C; Department Hematology Lille University Hospital Lille and INSERM UMR-S 1277 Lille France., Duployez N; Department Hematology Lille University Hospital Lille and INSERM UMR-S 1277 Lille France., Fenaux P; Department Hematology Hôpital Saint Louis, Assistance publique hôpitaux de paris, and Université de Paris Cité Paris France., Kosmider O; Division INSERM U1016, Assistance Publique-Hôpitaux de Paris, Cochin Hospital and Université Paris Cité, CNRS, INSERM Cochin Institute Paris France., Bouscary D; Division INSERM U1016, Assistance Publique-Hôpitaux de Paris, Cochin Hospital and Université Paris Cité, CNRS, INSERM Cochin Institute Paris France., de Graaf AO; Department of Laboratory Medicine, Laboratory of Hematology Radboud University Medical Center and Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands., Martens JHA; Department of Molecular Biology Radboud University Nijmegen The Netherlands., van der Reijden BA; Department of Laboratory Medicine, Laboratory of Hematology Radboud University Medical Center and Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands., Adès L; Department Hematology Hôpital Saint Louis, Assistance publique hôpitaux de paris, and Université de Paris Cité Paris France., Fontenay M; Division INSERM U1016, Assistance Publique-Hôpitaux de Paris, Cochin Hospital and Université Paris Cité, CNRS, INSERM Cochin Institute Paris France., Jansen JH; Department of Laboratory Medicine, Laboratory of Hematology Radboud University Medical Center and Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands.
Source: HemaSphere [Hemasphere] 2025 Jan 03; Vol. 9 (1), pp. e70034. Date of Electronic Publication: 2025 Jan 03 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39760001
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidine.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tiso+F%22">Tiso F</searchLink>; Department of Laboratory Medicine, Laboratory of Hematology Radboud University Medical Center and Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands.<br /><searchLink fieldCode="AU" term="%22In+'t+Hout+FEM%22">In 't Hout FEM</searchLink>; Department of Laboratory Medicine, Laboratory of Hematology Radboud University Medical Center and Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands.; Department of Hematology Radboud University Medical Center Nijmegen The Netherlands.<br /><searchLink fieldCode="AU" term="%22Knops+R%22">Knops R</searchLink>; Department of Laboratory Medicine, Laboratory of Hematology Radboud University Medical Center and Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kroeze+LI%22">Kroeze LI</searchLink>; Department of Pathology Radboud University Medical Center Nijmegen The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Rooij+A%22">van Rooij A</searchLink>; Department of Laboratory Medicine, Laboratory for Genetic, Endocrine, and Metabolic Diseases Radboud University Medical Center Nijmegen The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+de+Loosdrecht+AA%22">van de Loosdrecht AA</searchLink>; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC Vrije Universiteit Amsterdam Amsterdam The Netherlands.<br /><searchLink fieldCode="AU" term="%22Westers+TM%22">Westers TM</searchLink>; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC Vrije Universiteit Amsterdam Amsterdam The Netherlands.<br /><searchLink fieldCode="AU" term="%22Langemeijer+SMC%22">Langemeijer SMC</searchLink>; Department of Hematology Radboud University Medical Center Nijmegen The Netherlands.<br /><searchLink fieldCode="AU" term="%22Preudhomme+C%22">Preudhomme C</searchLink>; Department Hematology Lille University Hospital Lille and INSERM UMR-S 1277 Lille France.<br /><searchLink fieldCode="AU" term="%22Duployez+N%22">Duployez N</searchLink>; Department Hematology Lille University Hospital Lille and INSERM UMR-S 1277 Lille France.<br /><searchLink fieldCode="AU" term="%22Fenaux+P%22">Fenaux P</searchLink>; Department Hematology Hôpital Saint Louis, Assistance publique hôpitaux de paris, and Université de Paris Cité Paris France.<br /><searchLink fieldCode="AU" term="%22Kosmider+O%22">Kosmider O</searchLink>; Division INSERM U1016, Assistance Publique-Hôpitaux de Paris, Cochin Hospital and Université Paris Cité, CNRS, INSERM Cochin Institute Paris France.<br /><searchLink fieldCode="AU" term="%22Bouscary+D%22">Bouscary D</searchLink>; Division INSERM U1016, Assistance Publique-Hôpitaux de Paris, Cochin Hospital and Université Paris Cité, CNRS, INSERM Cochin Institute Paris France.<br /><searchLink fieldCode="AU" term="%22de+Graaf+AO%22">de Graaf AO</searchLink>; Department of Laboratory Medicine, Laboratory of Hematology Radboud University Medical Center and Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands.<br /><searchLink fieldCode="AU" term="%22Martens+JHA%22">Martens JHA</searchLink>; Department of Molecular Biology Radboud University Nijmegen The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Reijden+BA%22">van der Reijden BA</searchLink>; Department of Laboratory Medicine, Laboratory of Hematology Radboud University Medical Center and Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands.<br /><searchLink fieldCode="AU" term="%22Adès+L%22">Adès L</searchLink>; Department Hematology Hôpital Saint Louis, Assistance publique hôpitaux de paris, and Université de Paris Cité Paris France.<br /><searchLink fieldCode="AU" term="%22Fontenay+M%22">Fontenay M</searchLink>; Division INSERM U1016, Assistance Publique-Hôpitaux de Paris, Cochin Hospital and Université Paris Cité, CNRS, INSERM Cochin Institute Paris France.<br /><searchLink fieldCode="AU" term="%22Jansen+JH%22">Jansen JH</searchLink>; Department of Laboratory Medicine, Laboratory of Hematology Radboud University Medical Center and Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101740619%22">HemaSphere</searchLink> [Hemasphere] 2025 Jan 03; Vol. 9 (1), pp. e70034. <i>Date of Electronic Publication: </i>2025 Jan 03 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101740619 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2572-9241 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225729241%22">25729241 </searchLink><i>NLM ISO Abbreviation: </i>Hemasphere <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39760001
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/hem3.70034
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70034
    Titles:
      – TitleFull: High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidine.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tiso F
      – PersonEntity:
          Name:
            NameFull: In 't Hout FEM
      – PersonEntity:
          Name:
            NameFull: Knops R
      – PersonEntity:
          Name:
            NameFull: Kroeze LI
      – PersonEntity:
          Name:
            NameFull: van Rooij A
      – PersonEntity:
          Name:
            NameFull: van de Loosdrecht AA
      – PersonEntity:
          Name:
            NameFull: Westers TM
      – PersonEntity:
          Name:
            NameFull: Langemeijer SMC
      – PersonEntity:
          Name:
            NameFull: Preudhomme C
      – PersonEntity:
          Name:
            NameFull: Duployez N
      – PersonEntity:
          Name:
            NameFull: Fenaux P
      – PersonEntity:
          Name:
            NameFull: Kosmider O
      – PersonEntity:
          Name:
            NameFull: Bouscary D
      – PersonEntity:
          Name:
            NameFull: de Graaf AO
      – PersonEntity:
          Name:
            NameFull: Martens JHA
      – PersonEntity:
          Name:
            NameFull: van der Reijden BA
      – PersonEntity:
          Name:
            NameFull: Adès L
      – PersonEntity:
          Name:
            NameFull: Fontenay M
      – PersonEntity:
          Name:
            NameFull: Jansen JH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 01
              Text: 2025 Jan 03
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2572-9241
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: HemaSphere
              Type: main
ResultId 1